Marwa Tlijani

ORCID: 0000-0002-8868-1626
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Economics and Policy
  • Pharmacovigilance and Adverse Drug Reactions
  • Safe Handling of Antineoplastic Drugs
  • Pediatric Pain Management Techniques
  • Drug Transport and Resistance Mechanisms
  • Healthcare Systems and Practices
  • Pharmacological Effects and Toxicity Studies
  • Drug Solubulity and Delivery Systems
  • Pharmaceutical Quality and Counterfeiting
  • Health, Medicine and Society
  • Protein Interaction Studies and Fluorescence Analysis
  • Pharmaceutical studies and practices
  • Pain Management and Opioid Use
  • Pharmaceutical Practices and Patient Outcomes
  • Health Systems, Economic Evaluations, Quality of Life

Hospital Fatuma Bourguiba Monastir
2023

University of Monastir
2021

Institut Salah-Azaïz
2020

Our work is aimed at exploring the composition and properties of microemulsion (ME), as a drug delivery system, to enhance permeability across gastrointestinal (GI) barrier fenofibrate, BCS class II drug. It prodrug that converted rapidly after oral administration into major active metabolite which fenofibric acid. undergoes nearly complete presystemic metabolism. Its main drawback low bioavailability metabolite. A quick selection excipients was made based on capacity solubilization value...

10.1155/2021/5538940 article EN Journal of Nanomaterials 2021-07-01

Contexte : Le bilan biologique fait partie intégrante du processus de diagnostic qui oriente les décisions prise en charge thérapeutique. Cependant, ces analyses restent sujettes à des interférences endogènes ou exogènes altèrent le résultat. Objectif L’objectif notre travail était fournir un aperçu actualisé et complet plus documentées dues aux médicaments, afin que l’interprétation résultats soit fiable la patient, meilleure. Sources données Il s’agit d’une revue systématique exhaustive...

10.4212/cjhp.v74i4.3200 article FR The Canadian Journal of Hospital Pharmacy 2021-09-28

Biological assessment is an integral part of the diagnostic process that guides therapeutic management decisions. However, these analyses remain subject to interference from endogenous or exogenous factors, which may alter results.

10.4212/c-jhp.v74i4.3200 article EN PubMed 2021-01-01
Coming Soon ...